SARS-CoV-2的疫苗研發製造的策略:
1.去活化病毒疫苗(inactivated virus vaccines):
病毒已經是被用物理的或化學的去活化(Viruses are physically or chemically inactivated),但是仍然保存病毒顆粒的完整性(preserve the integrity of the virus paticle),它們充當免疫抗原(immunogen)。
2.病毒類似的顆粒或奈米顆粒的疫苗(Virus -like particle or nanoparticle vaccines):
結構性的病毒的蛋白質已經被共同表現(structural viral proteins are co-expressed),,形成沒有感染性的顆粒(form non-infectious particles),來當作疫苗的免疫抗原(vaccine immunogen),它們類似真實的類病毒(real virions)但是缺乏病毒的基因體(lack the virus genome)。
3.蛋白質次單元的疫苗(Protein subunit vaccines):
這種策略只有包括關鍵性的病毒的蛋白質或胜太(only key proteins or peptides),它們能夠在細菌(bacteria)酵母菌(yeast)昆蟲或脯乳類細胞(insect or mammalian cells)中在人體外被製造(manufactured in vitro),目前最大多數的在臨床期和臨床前期階段登錄在案候選的SARS-CoV-2疫苗,都是根據這種策略研發製造的。
4.病毒引導導航導向的疫苗(virus-vectored vaccines):
編碼致病原抗原的基因(genes encoding pathogen antigen),是被導入非複製的或複製的病毒載體(cloned into non-replicating or replicating virus vectors)例如腺病毒(adenvirus),這些抗原在免疫化作用後,由被轉換的宿主細胞產生(the antigens are produced by transduced host cells after immunization)。
5.DNA和mRNA疫苗(DNA and mRNA vaccines):
DNA和mRNA疫苗(DNA and mRNA vaccines),有可以快速製造用來抵抗突現性的致病原的優勢(DNA and mRNA vaccines have the advantage of rapid manufacturing against pathogens),DNA 疫苗(DNA vaccines),藉由再重組的DNA 質體所編碼的病毒的抗原(viral antigens encoded by a recombinant DNA plasmid),在宿主細胞中經由次序性的轉錄到轉譯的過程產生(produced in host cells via sequential transcription-to translation process)。相反地,mRNA 疫苗(mRNA vaccines)是藉由在人體外的轉錄過程被合成(synthesized by in vitro transcription),它們經由在人體內的直接的蛋白質轉譯,在細胞質中產生病毒的抗原(they produce viral antigens in the cytoplasm through direct protein trsnslation in vivo)。
6.活的減毒的病毒疫苗(Live-attenuated virus vaccines):
在這種策略中,病毒是藉由在人體外或人體內的過程或反向的遺傳的突變的產生作用而被減毒(virus is attenuated by in vitro or in vivo passage or reverse genetic mutagenesis),這個結果病毒變成沒有致病性或變成弱的致病性(the resulting virus becomes non-pathogenic or weakly pathogenic),但是仍然維持保持類似活的病毒感染的免疫抗原性(retains immunogenecity by mimicking live virus infection)。
資料來源:
Viral targets for vaccines against COVID-19
Nature Reviews Immunology(2020)18 DEC 2020)
感謝 #Cheng_Sheng_Tai 醫師提供資料
同時也有10000部Youtube影片,追蹤數超過2,910的網紅コバにゃんチャンネル,也在其Youtube影片中提到,...
「they transcription」的推薦目錄:
- 關於they transcription 在 臨床筆記 Facebook 的最佳貼文
- 關於they transcription 在 蕭叔叔英式英文學會 Uncle Siu's British English Club Facebook 的最佳解答
- 關於they transcription 在 貓婆選物所 Facebook 的最讚貼文
- 關於they transcription 在 コバにゃんチャンネル Youtube 的精選貼文
- 關於they transcription 在 大象中醫 Youtube 的最佳解答
- 關於they transcription 在 大象中醫 Youtube 的最讚貼文
- 關於they transcription 在 Transcription and Translation - Protein Synthesis From DNA 的評價
they transcription 在 蕭叔叔英式英文學會 Uncle Siu's British English Club Facebook 的最佳解答
【#迷上英式英文】英國首相Theresa May辭職演說
蕭叔短評:保持她一貫風格,好悶。
Ever since I first stepped through the door behind me as Prime Minister, I have striven to make the United Kingdom a country that works not just for a privileged few, but for everyone. And to honour the result of the EU referendum.Back in 2016, we gave the British people a choice. Against all predictions, the British people voted to leave the European Union.
I feel as certain today as I did three years ago that in a democracy, if you give people a choice you have a duty to implement what they decide.I have done my best to do that. I negotiated the terms of our exit and a new relationship with our closest neighbours that protects jobs, our security and our Union. I have done everything I can to convince MPs to back that deal. Sadly, I have not been able to do so.
I tried three times. I believe it was right to persevere, even when the odds against success seemed high. But it is now clear to me that it is in the best interests of the country for a new Prime Minister to lead that effort.
So I am today announcing that I will resign as leader of the Conservative and Unionist Party on Friday 7 June so that a successor can be chosen. I have agreed with the Party Chairman and with the Chairman of the 1922 Committee that the process for electing a new leader should begin in the following week. I have kept Her Majesty the Queen fully informed of my intentions, and I will continue to serve as her Prime Minister until the process has concluded.
It is, and will always remain, a matter of deep regret to me that I have not been able to deliver Brexit. It will be for my successor to seek a way forward that honours the result of the referendum. To succeed, he or she will have to find consensus in Parliament where I have not. Such a consensus can only be reached if those on all sides of the debate are willing to compromise.
For many years the great humanitarian Sir Nicholas Winton – who saved the lives of hundreds of children by arranging their evacuation from Nazi-occupied Czechoslovakia through the Kindertransport – was my constituent in Maidenhead. At another time of political controversy, a few years before his death, he took me to one side at a local event and gave me a piece of advice. He said, ‘Never forget that compromise is not a dirty word. Life depends on compromise.’ He was right.
As we strive to find the compromises we need in our politics – whether to deliver Brexit, or to restore devolved government in Northern Ireland – we must remember what brought us here. Because the referendum was not just a call to leave the EU but for profound change in our country. A call to make the United Kingdom a country that truly works for everyone. I am proud of the progress we have made over the last three years.
We have completed the work that David Cameron and George Osborne started: the deficit is almost eliminated, our national debt is falling and we are bringing an end to austerity. My focus has been on ensuring that the good jobs of the future will be created in communities across the whole country, not just in London and the South East, through our Modern Industrial Strategy.
We have helped more people than ever enjoy the security of a job. We are building more homes and helping first-time buyers onto the housing ladder - so young people can enjoy the opportunities their parents did. And we are protecting the environment, eliminating plastic waste, tackling climate change and improving air quality. This is what a decent, moderate and patriotic Conservative Government, on the common ground of British politics, can achieve - even as we tackle the biggest peacetime challenge any government has faced.
I know that the Conservative Party can renew itself in the years ahead. That we can deliver Brexit and serve the British people with policies inspired by our values. Security; freedom; opportunity. Those values have guided me throughout my career.
But the unique privilege of this office is to use this platform to give a voice to the voiceless, to fight the burning injustices that still scar our society. That is why I put proper funding for mental health at the heart of our NHS long-term plan. It is why I am ending the postcode lottery for survivors of domestic abuse. It is why the Race Disparity Audit and gender pay reporting are shining a light on inequality, so it has nowhere to hide. And that is why I set up the independent public inquiry into the tragedy at Grenfell Tower – to search for the truth, so nothing like it can ever happen again, and so the people who lost their lives that night are never forgotten.
Because this country is a Union.Not just a family of four nations. But a union of people – all of us. Whatever our background, the colour of our skin, or who we love. We stand together. And together we have a great future.
Our politics may be under strain, but there is so much that is good about this country. So much to be proud of. So much to be optimistic about. I will shortly leave the job that it has been the honour of my life to hold – the second female Prime Minister but certainly not the last. I do so with no ill-will, but with enormous and enduring gratitude to have had the opportunity to serve the country I love.
Video Source: BBC News
Transcription: The Guardian
they transcription 在 貓婆選物所 Facebook 的最讚貼文
看過一些數據,一年中死於化療的數字比本身癌症還多。
【美國終於承認手術或化療後癌細胞反而加速擴散】 - 路透社報道
科學家一項最近研究發現,有些癌症患者在接受手術、化療或放療後,癌細胞反而加速擴散,造成這種現象的原因之一是人體一種名為TGF-be-ta物質。因此,控制TGF-be-ta物質在人體內的含量,才是治癒癌症的關鍵。
來自美國田納西州範德比爾特大學的研究人員在老鼠身上試驗發現,患有乳腺癌的老鼠在服用化療物質“阿黴素”或接受放療後,體內的TGF-be-ta物質含量提高,刺激癌細胞向肺部轉移。而使用某種抗體抑制它們體內的TGF-be-ta含量則能夠遏制癌細胞擴散。
參考連結:Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838926/
此前有科學家提出,動物體內的原發性腫瘤可能會抑制其他腫瘤生長,但一旦原發性腫瘤被從體內清除,其他被抑制腫瘤可能會就此瘋長。而科學此次研究顯示,TGF-be-ta就是這樣一種既能抑制腫瘤生長,也能刺激癌細胞擴散的物質。
主持研究的卡洛斯.。啊特亞加博士補充說,可能還有其他物質與TGF-be-ta一樣對癌症的治療有類此的影響。他們希望通過對TGF-be-ta的研究得出更多結論。 以上訊息在10月8日的《參考訊息》報也有報導。
看來主張手術或放化療治療癌症的人,良心終於被發現了。 人類自從3000年前發明瞭藥物以來,200年前發現了抗生素,人類的疾病就更複雜,更多,更難治。
很多慢性病,免疫系統紊亂症,都與藥物和抗生素的濫用有很大的關係。人的耐藥性越強。人就更難戰勝病魔。而癌症自然也有它的天敵。眾所周知醫學界對癌症束手無策。
醫學界奪命奪錢三招“手術、化療、放療”。目前醫學科技很發達,世界各國投入無數財力物力去研究醫學,但是卻對絕大多數的慢性疾病無能為力,這不能不說是個人類天大的笑話。
1、成年人每人每天都有3000-6000個癌細胞產生(由於基因突變而讓正常細胞變成癌細胞,基因突變原因很多,化學藥物,肉類,動物荷爾蒙、空氣汙染等等)。
2、但人每一天誕生的癌細胞幾乎都被人體自身自然殺手細胞(NK細胞)殺滅了。所以不是人人都會患上癌症.當免疫系統下降,也就是自然殺手細胞弱了,癌細胞就佔上風。久而久之5-10年以上就會得到癌症.如果我們能讓癌症病人身體裡的自然殺手細胞變強,恢復活力,對付癌症是簡單的事。
所以癌症病人只能靠自己也就是自身免疫細胞-自然殺手細胞(NK細胞)來對付癌症。
3、讓自然殺手細胞(NK細胞)恢復活力的唯一途徑是營養70%、心情10%、運動10%、休息10%(世界衛生組織的健康的四大基石)。
4、只要有充足的營養,自然細胞就能恢復到以前的活力來殺滅癌細胞。(這個世界一物降一物,但一物應該是人體的細胞而不是藥物,也不是植物,更不是動物。人的免疫細胞是可以對付世界上所有的病毒和細菌,比如非典病毒,艾滋病毒,埃博拉病毒,流感病毒,關鍵是人的免疫細胞要足夠的強。例外:但人的免疫細胞沒有辦法對付毒藥。
5、醫學上常規不得已用藥物和化療、放療、電療方法,除了把癌細胞部分殺滅外,反而把正常的大量的自然殺手細胞殺滅.醫學界奪命奪錢三招“手術、化療、放療”!所以手術藥物和化療放療有時能減輕病人的痛苦同時反而加速癌症病人的死亡.
6、為什麼國內的癌症研究者都是研究藥物如何殺滅癌細胞(治標)。為什麼不能研究讓人體內的自然殺手細胞增強來殺滅癌細胞呢(治本)?只有0.5%的經過化療放療的病人能活過超過5年!!
7、世界上最好的醫生是自己的免疫系統、免疫細胞,而不是醫生和藥物!!只有本人的免疫系統(自然殺手免疫細胞)才能殺滅癌細胞。可是藥物和化放療卻會快速讓人的免疫系統下降。
8、請癌症病人去新華書店購買《營養免疫學》陳昭妃癌症研究博士著,《不要讓不懂營養學的醫生殺了你》雷.D.斯全德醫學博士著。《別讓醫生殺了你》, 《食物是最好的醫生》,《醫生對你隱瞞了什麼》...等最新學科書籍。但是闡述得最完整最好的還是《營養免疫學》這本書。
9 四大基石裡的休息和運動促使免疫力提高。晚上安靜下來睡覺的時候,是人體內免疫細胞正在大量修復身體破損的細胞的時候,所以晚上也是最需要休息和營養的時候。
10、偶然我們在報上看到有些極少數癌症病人得了癌症不治,反而過了幾年後身體的癌症症狀全無,經檢測沒有癌細胞的存在.這是因為這個癌症病人平常的飲食心情運動休息讓體內的自然殺手細胞得到增強來殺滅癌細胞.也就是自愈力了——自已治病的能力。治癌不能靠高科技,而只能靠自然的力量、自身的力量。
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
Abstract
We investigated whether TGF-β induced by anticancer therapies accelerates tumor progression. Using the MMTV/PyVmT transgenic model of metastatic breast cancer, we show that administration of ionizing radiation or doxorubicin caused increased circulating levels of TGF-β1 as well as increased circulating tumor cells and lung metastases. These effects were abrogated by administration of a neutralizing pan–TGF-β antibody. Circulating polyomavirus middle T antigen–expressing tumor cells did not grow ex vivo in the presence of the TGF-β antibody, suggesting autocrine TGF-β is a survival signal in these cells. Radiation failed to enhance lung metastases in mice bearing tumors that lack the type II TGF-β receptor, suggesting that the increase in metastases was due, at least in part, to a direct effect of TGF-β on the cancer cells. These data implicate TGF-β induced by anticancer therapy as a prometastatic signal in tumor cells and provide a rationale for the simultaneous use of these therapies in combination with TGF-β inhibitors.
Go to:
Introduction
TGF-β is both a tumor suppressor and a tumor promoter. The TGF-β ligands bind to cognate serine/threonine kinase transmembrane receptors, which in turn phosphorylate and activate the Smad family of signal transducers. Once activated, Smad2 and Smad3 associate with Smad4 and translocate to the nucleus, where they regulate the transcription of genes involved in cell cycle arrest and apoptosis (1), essential for the tumor suppressor role of the TGF-βs. Indeed, loss or attenuation of TGF-β signaling in epithelial cells and stroma is permissive for epithelial cell transformation (2, 3). On the other hand, introduction of dominant-negative TGF-β receptors into metastatic cancer cells has been shown to inhibit epithelial-to-mesenchymal transdifferentiation, motility, invasiveness, and survival, supporting the tumor promoter role in TGF-β in fully transformed cells (reviewed in ref. 4). Most carcinomas retain TGF-β receptors but attenuate or lose the Smad-dependent antimitogenic effect while, in some cases, gaining prometastatic abilities in response to TGF-β. In addition, excess production and/or activation of TGF-β by cancer cells can contribute to tumor progression by paracrine mechanisms involving modulation of the tumor microenvironment (2, 5, 6). These data have provided a rationale in favor of blockade of autocrine/paracrine TGF-β signaling in human cancers with a therapeutic intent.
In addition to Smads, TGF-β can stimulate several transforming signaling pathways (7). TGF-β has previously been shown to protect transformed cells from apoptosis (8–10). One possible mechanism for this cellular response is TGF-β–induced activation of PI3K and its target, the serine-threonine kinase Akt (11, 12), a signaling program associated with resistance to anticancer drugs. Some tumors resistant to conventional anticancer chemotherapy overexpress TGF-βs (13, 14), and inhibitors of TGF-β have been shown to reverse this resistance (15). In addition, overexpression of TGF-β ligands have been reported in most cancers, and high levels of these in tumor tissues and/or serum are associated with early metastatic recurrences and/or poor patient outcome (16–21).
In transgenic models of breast cancer, TGF-β signaling enhances the metastatic progression of established mammary tumors induced by oncogenes such as Neu/ErbB2 or polyomavirus middle T antigen (PyVmT) (22–24). Furthermore, in transgenic mice expressing the PyVmT oncogene under the control of the MMTV/LTR mammary promoter, conditional induction of active TGF-β1 for as little as 2 weeks increases lung metastases by more than 10-fold (10). Some anticancer therapies have been shown to induce TGF-β systemically or in situ (25–28). Therefore, we speculated that in tumors resistant to anticancer therapies or in resistant subpopulations within those tumors, treatment-induced TGF-β would provide a survival signal to cancer cells potentially accelerating tumor progression immediately after therapy. Using the MMTV/PyVmT transgenic model of metastatic breast cancer, we show here that administration of ionizing radiation or doxorubicin caused increased circulating levels of TGF-β1 as well as increased circulating tumor cells and lung metastases. These effects were abrogated by administration of a neutralizing pan–TGF-β antibody. Radiation did not increase lung metastases in mice bearing tumors that lack the type II TGF-β receptor (TβRII). These data implicate TGF-β induced by anticancer therapy as a prometastatic signal in tumors and thus provide a rationale for the simultaneous use of these therapies in combination with TGF-β inhibitors.
Go to:
Results
Thoracic radiation and chemotherapy increase circulating TGF-β1.
We administered 10 Gy to the thoraxes or pelvises of 8-week-old FVB virgin female mice. Blood was collected 24 hours after irradiation. We observed an approximate 2-fold increase in plasma TGF-β1 in irradiated mice over controls regardless of the site of radiation (thorax, P = 0.03; pelvis, P = 0.02; Figure Figure1A),1A), while TGF-β2 levels did not change (data not shown). Similar results were obtained in 8-week-old MMTV/PyVmT transgenic mice and in nontransgenic mice transplanted with MMTV/PyVmT tumor cells stably transfected with a luciferase expression vector (P = 0.015 and P = 0.007, respectively, versus controls; Figure Figure1B).1B). Levels of TGF-β1 remained higher than controls 7 days after radiation (data not shown). To expand these results to other anticancer therapies, we examined the effect of the DNA-intercalating agent and topoisomerase II inhibitor doxorubicin (Adriamycin). Transgenic mice were treated 3 times with doxorubicin (5 mg/kg i.p.) at 21-day intervals starting at week 8. In plasma collected on week 15, TGF-β1 was also elevated 2-fold compared with untreated mice (P = 0.009; Figure Figure1C),1C), whereas TGF-β2 levels remained constant. To measure activated TGF-β1 in the lung tissue harvested 5 weeks after radiation, we used a TGF-β1 bioassay that uses mink lung epithelial cells stably expressing a plasminogen activator inhibitor–1/luciferase reporter (PAI-1/luciferase reporter) (29). Tissue lysates from irradiated mouse lungs induced a 2-fold increase in active TGF-β1 compared with nonirradiated lung tissue lysates (P = 0.0008; Figure Figure1D). 1D).
they transcription 在 Transcription and Translation - Protein Synthesis From DNA 的推薦與評價
This biology video tutorial provides a basic introduction into transcription and translation which explains protein synthesis starting from ... ... <看更多>